Alterations in the Salivary Proteome and N-Glycome of Sjögren's Syndrome Patients.
暂无分享,去创建一个
L. Criswell | C. Shiboski | S. Fisher | H. Witkowska | K. Williams | Maria E. Hassis | M. Laurance | K. Ona | M. Gormley | Andrew B Dykstra | Richard K. Niles | Matthew E. Albertolle | A. Prakobphol | S. Hall | N. Prasad | Susan Fisher | Katherine E. Williams | Matthew E Albertolle | Matthew J Gormley
[1] Caitlin P. McHugh,et al. Genome‐Wide Association Analysis Reveals Genetic Heterogeneity of Sjögren's Syndrome According to Ancestry , 2017, Arthritis & rheumatology.
[2] L. Criswell,et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome , 2016, Annals of the rheumatic diseases.
[3] G. Leoni,et al. Annexin A1: shifting the balance towards resolution and repair , 2016, Biological chemistry.
[4] Mototsugu Nagao,et al. Association of psoriasis with Hashimoto's thyroiditis, Sjögren's syndrome and dermatomyositis , 2016, The Journal of dermatology.
[5] N. Karlsson,et al. Reduced Mucin-7 (Muc7) Sialylation and Altered Saliva Rheology in Sjögren's Syndrome Associated Oral Dryness* , 2015, Molecular & Cellular Proteomics.
[6] S. Fisher,et al. Mass spectrometry-based analyses showing the effects of secretor and blood group status on salivary N-glycosylation , 2015, Clinical Proteomics.
[7] P. Veith,et al. Gingival crevicular fluid proteomes in health, gingivitis and chronic periodontitis. , 2015, Journal of periodontal research.
[8] Jin Lin,et al. Biomarkers for Primary Sjögren’s Syndrome , 2015, Genom. Proteom. Bioinform..
[9] Chi‐Huey Wong,et al. Galectin-3 Binding Protein and Galectin-1 Interaction in Breast Cancer Cell Aggregation and Metastasis. , 2015, Journal of the American Chemical Society.
[10] D. Wong,et al. Identification of Sjögren's syndrome oral fluid biomarker candidates following high-abundance protein depletion. , 2015, Rheumatology.
[11] Kamran Nazmi,et al. Histatin‐1, a histidine‐rich peptide in human saliva, promotes cell‐substrate and cell‐cell adhesion , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[12] L. Criswell,et al. The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjögren's syndrome , 2015, Annals of the rheumatic diseases.
[13] A. Vissink,et al. Ig Gene Analysis Reveals Altered Selective Pressures on Ig-Producing Cells in Parotid Glands of Primary Sjögren’s Syndrome Patients , 2015, The Journal of Immunology.
[14] L. Borradori,et al. Plakins, a versatile family of cytolinkers: roles in skin integrity and in human diseases. , 2014, The Journal of investigative dermatology.
[15] Uroš Andjelković,et al. Isolation, biochemical characterization and anti-bacterial activity of BPIFA2 protein. , 2014, Archives of oral biology.
[16] D. Spieler,et al. Acute transverse myelitis and psoriasiform dermatitis associated with Sjoegren’s syndrome: a case report , 2014, BMC Research Notes.
[17] S. Knudsen,et al. Unique protein signature of circulating microparticles in systemic lupus erythematosus. , 2013, Arthritis and rheumatism.
[18] W. Kuo,et al. Diagnostic model of saliva peptide finger print analysis of primary Sjögren's syndrome patients by using weak cation exchange magnetic beads , 2013, Bioscience reports.
[19] L. Herrinton,et al. The association of psoriasis with autoimmune diseases. , 2012, Journal of the American Academy of Dermatology.
[20] M. Aslan,et al. Polymorphism in the TNF-alpha gene promoter at position -1031 is associated with increased circulating levels of TNF-alpha, myeloperoxidase and nitrotyrosine in primary Sjögren's syndrome. , 2012, Clinical and experimental rheumatology.
[21] M. Gucek,et al. Quantitative proteomics of parotid saliva in primary Sjögren's syndrome , 2012, Proteomics.
[22] P. Vlachoyiannopoulos,et al. Subgroups of Sjögren syndrome patients according to serological profiles. , 2012, Journal of autoimmunity.
[23] L. Criswell,et al. Primary Sjögren's syndrome as a systemic disease: A study of participants enrolled in an International Sjögren's syndrome registry , 2012, Arthritis care & research.
[24] Hua Xiao,et al. Proteomic analysis of microvesicles in human saliva by gel electrophoresis with liquid chromatography-mass spectrometry. , 2012, Analytica chimica acta.
[25] Y. Matsuo,et al. Extremely high salivary β2‐microglobulin and Na+ levels in a Sjögren syndrome patient , 2012, International journal of rheumatic diseases.
[26] L. Criswell,et al. American College of Rheumatology classification criteria for Sjögren's syndrome: A data‐driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance Cohort , 2012, Arthritis care & research.
[27] W. Haddon,et al. Discovery of putative salivary biomarkers for Sjögren's syndrome using high resolution mass spectrometry and bioinformatics. , 2012, Journal of oral science.
[28] J. Pers,et al. In Sjögren's syndrome, B lymphocytes induce epithelial cells of salivary glands into apoptosis through protein kinase C delta activation. , 2012, Autoimmunity reviews.
[29] Sean L. Seymour,et al. CysTRAQ - A combination of iTRAQ and enrichment of cysteinyl peptides for uncovering and quantifying hidden proteomes. , 2012, Journal of proteomics.
[30] S. Bombardieri,et al. Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes , 2011, Arthritis research & therapy.
[31] S. Bombardieri,et al. Correspondence between salivary proteomic pattern and clinical course in primary Sjögren syndrome and non-Hodgkin's lymphoma: a case report , 2011, Journal of Translational Medicine.
[32] M. Aslan,et al. Polymorphism in the TNF-alpha Gene Promoter is Associated With Increased Circulating Levels of TNF-alpha, Myeloperoxidase and Nitrotyrosine in Primary Sjogren's Syndrome , 2011 .
[33] L. Bingle,et al. Distant cousins: genomic and sequence diversity within the BPI fold-containing (BPIF)/PLUNC protein family. , 2011, Biochemical Society transactions.
[34] Ruth L. Seal,et al. Systematic nomenclature for the PLUNC/PSP/BSP30/SMGB proteins as a subfamily of the BPI fold-containing superfamily. , 2011, Biochemical Society transactions.
[35] L. Bingle,et al. Distribution of human PLUNC/BPI fold-containing (BPIF) proteins. , 2011, Biochemical Society transactions.
[36] L. Punzi,et al. Anti-annexins autoantibodies: their role as biomarkers of autoimmune diseases. , 2011, Autoimmunity reviews.
[37] A. Vissink,et al. Identification of autoantibody biomarkers for primary Sjögren's syndrome using protein microarrays , 2011, Proteomics.
[38] Dylan J. Sorensen,et al. A lectin affinity workflow targeting glycosite-specific, cancer-related carbohydrate structures in trypsin-digested human plasma. , 2011, Analytical biochemistry.
[39] J. Duarte,et al. Salivary peptidomics , 2010, Expert review of proteomics.
[40] C. Fanali,et al. Proteomic approaches to Sjögren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease. , 2010, Autoimmunity reviews.
[41] Y Wu,et al. Initial comparison of proteomic profiles of whole unstimulated saliva obtained from generalized aggressive periodontitis patients and healthy control subjects. , 2009, Journal of periodontal research.
[42] A I Bolstad,et al. The minor salivary gland proteome in Sjögren's syndrome. , 2009, Oral diseases.
[43] S. Cross,et al. Characterisation and expression of SPLUNC2, the human orthologue of rodent parotid secretory protein , 2009, Histochemistry and Cell Biology.
[44] L. Criswell,et al. An early view of the international Sjögren's syndrome registry. , 2009, Arthritis and rheumatism.
[45] D. Wong,et al. Salivary Diagnostics , 2019, Saliva and Salivary Diagnostics.
[46] Y. Fleissig,et al. Different proteomic protein patterns in saliva of Sjögren's syndrome patients. , 2009, Oral diseases.
[47] A. Vissink,et al. Systems biology analysis of Sjögren's syndrome and mucosa-associated lymphoid tissue lymphoma in parotid glands. , 2009, Arthritis and rheumatism.
[48] D. Wong,et al. Glycoprofiling of the Human Salivary Proteome , 2009, Clinical Proteomics.
[49] John R Yates,et al. The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. , 2008, Journal of proteome research.
[50] S. Cha,et al. Decreased levels of soluble receptor for advanced glycation end products in patients with primary Sjögren’s syndrome , 2008, Rheumatology International.
[51] S. Bombardieri,et al. Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjögren's syndrome? , 2008, Autoimmunity reviews.
[52] F. Watt,et al. Mice deficient in involucrin, envoplakin, and periplakin have a defective epidermal barrier , 2007, The Journal of cell biology.
[53] A. Vissink,et al. Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. , 2007, Arthritis and rheumatism.
[54] C. Fanali,et al. Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment. , 2007, Arthritis and rheumatism.
[55] Chiara Baldini,et al. Proteome analysis of whole saliva: A new tool for rheumatic diseases – the example of Sjögren's syndrome , 2007, Proteomics.
[56] P. Fox. Autoimmune Diseases and Sjögren's Syndrome , 2007, Annals of the New York Academy of Sciences.
[57] D. Waisman,et al. Annexin 2-mediated enhancement of cytomegalovirus infection opposes inhibition by annexin 1 or annexin 5. , 2007, The Journal of general virology.
[58] G. Illei,et al. Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. , 2006, Rheumatology.
[59] W. Ens,et al. Deamidation of -Asn-Gly- sequences during sample preparation for proteomics: Consequences for MALDI and HPLC-MALDI analysis. , 2006, Analytical chemistry.
[60] Joseph A Loo,et al. Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry. , 2006, Journal of proteome research.
[61] X. Mariette,et al. Anti-α-fodrin autoantibodies are not useful diagnostic markers of primary Sjögren’s syndrome , 2005 .
[62] T. Witte. Antifodrin Antibodies in Sjögren's Syndrome: A Review , 2005, Annals of the New York Academy of Sciences.
[63] S. Klebanoff. Myeloperoxidase: friend and foe , 2005, Journal of leukocyte biology.
[64] M. Takiguchi,et al. Autoimmunity against a Tissue Kallikrein in IQI/Jic Mice , 2005, Journal of Biological Chemistry.
[65] E. Ben-Chetrit,et al. Anti-SSA/Ro and anti-SSB/La antibodies in serum and saliva of patients with Sjogren's syndrome , 1993, Clinical Rheumatology.
[66] X. Mariette,et al. Anti-{alpha}-fodrin autoantibodies are not useful diagnostic markers of primary Sjögren's syndrome. , 2005, Annals of the rheumatic diseases.
[67] I. Bhattacharyya,et al. Receptor of advanced glycation end product (RAGE) expression in the minor salivary glands of patients with Sjo˝gren's syndrome: a preliminary study , 2004, Scandinavian journal of rheumatology.
[68] R. Gay,et al. Galectin 3 and its binding protein in rheumatoid arthritis. , 2003, Arthritis and rheumatism.
[69] J. Sabio,et al. Salivary and serum beta2-microglobulin and gamma-glutamyl-transferase in patients with primary Sjögren syndrome and Sjögren syndrome secondary to systemic lupus erythematosus. , 2003, Clinica chimica acta; international journal of clinical chemistry.
[70] S. Gorr,et al. Expression and anti-bacterial activity of human parotid secretory protein (PSP). , 2003, Biochemical Society transactions.
[71] M. Paul-Clark,et al. The FASEB Journal express article 10.1096/fj.02-0239fje. Published online December 3, 2002. Aberrant inflammation and resistance to glucocorticoids in Annexin 1 –/ – Mouse , 2022 .
[72] C. Vitali. Classification criteria for Sjögren’s syndrome , 2003, Annals of the rheumatic diseases.
[73] R. Jonsson,et al. Genetic aspects of Sjögren's syndrome , 2002, Arthritis research.
[74] H. Ling,et al. The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. , 2002, The Biochemical journal.
[75] Z. Dlamini,et al. Kallikrein and Kinin Receptor Expression in Inflammation and Cancer , 2001, Biological chemistry.
[76] P. Pizcueta,et al. Circulating concentrations of soluble L-selectin (CD62L) in patients with primary Sjögren's syndrome , 2000, Annals of the rheumatic diseases.
[77] Jamin,et al. Increased N‐Linked Glycosylation Leading to Oversialylation of Monomeric Immunoglobulin A1 from Patients with Sjögren's Syndrome , 2000, Scandinavian journal of immunology.
[78] S. Parkkila,et al. Salivary carbonic anhydrase isoenzyme VI , 1999, The Journal of physiology.
[79] E. Donadi,et al. Kininogen-kallikrein-kinin system in plasma and saliva of patients with Sjögren's syndrome. , 1998, The Journal of rheumatology.
[80] A. Silman,et al. Sjögren's syndrome: a community-based study of prevalence and impact. , 1998, British journal of rheumatology.
[81] A. Burlingame,et al. Human low-molecular-weight salivary mucin expresses the sialyl lewisx determinant and has L-selectin ligand activity. , 1998, Biochemistry.
[82] R. Timpl,et al. Mac‐2 binding protein is a cell‐adhesive protein of the extracellular matrix which self‐assembles into ring‐like structures and binds β1 integrins, collagens and fibronectin , 1998, The EMBO journal.
[83] G. Ciliberto,et al. Structural characterization of a biologically active human lipocortin 1 expressed in Escherichia coli. , 1993, European journal of biochemistry.
[84] A. Linde,et al. Salivary kallikrein in Sjögren's syndrome. , 1988, Clinical and experimental rheumatology.
[85] D. Proud,et al. Kinin formation: mechanisms and role in inflammatory disorders. , 1988, Annual review of immunology.
[86] M. Levine,et al. Biochemical and biophysical comparison of two mucins from human submandibular-sublingual saliva. , 1987, Archives of biochemistry and biophysics.
[87] Y. Yang,et al. The primary structure and functional characterization of the neutral histidine-rich polypeptide from human parotid secretion. , 1986, The Journal of biological chemistry.
[88] J. Jenzano,et al. Evaluation of kallikrein in human parotid and submandibular saliva. , 1986, Archives of oral biology.
[89] L. Tabak,et al. Purification of a low-molecular-weight, mucin-type glycoprotein from human submandibular-sublingual saliva. , 1982, Carbohydrate research.
[90] H. Grey,et al. Beta2 microglobulin and lymphocytic infiltration in Sjögren's syndrome. , 1975, The New England journal of medicine.
[91] J. J. Bunim,et al. SJÖGREN'S SYNDROME: A Clinical, Pathological, and Serological Study of Sixty-two Cases , 1965, Medicine.